Skip to content
Screener

Stryker SYK Knees — Net Sales

Other product segments

Trauma and Extremities
$1.04B+9.5%
Instruments
$920M+9.8%
Medical
$902M-4.6%
Endoscopy
$868M+0.1%
Ortho Tech
$646M
Vascular
$517M+27.3%
Hips
$460M+3.8%
Spine
$8M-95.7%

Similar metrics at other companies

POS
POSTNut butters — Net Sales
$101.3M+392%
POS
POSTPet Food — Net Sales
$346.7M-19.9%
Otis Worldwide logo
OTISService sales — Net Sales
$2.58B+11.3%
Central Garden & Pet Company logo
CENTPet — Net Sales
$476.84M+5.1%
Central Garden & Pet Company logo
CENTOther pet products — Net Sales
$164M+7.3%
Corteva logo
CTVAFungicides — Net Sales
$222M+2.8%

Other financials

Income statement

See full
Revenue$6.6B+9.4%
Gross profit$4.5B+17.1%
Operating income$1.7B+49.1%
Net income$1.3B+44.3%
EPS (diluted)$3.30+44.1%

Balance sheet

See full
Cash & equivalents$3.4B+42.8%
Total debt$14.2B-15.2%
Total assets$47.9B+3.5%

Cash flow

See full
Operating cash flow$1.3B+13.5%
CapEx$202.0M+10.4%
Free cash flow$1.1B+14.1%

Valuation

See full
Market cap$124.86B-14.4%
Enterprise value$135.66B-15.3%
P/E33.5×-16.5×
P/S4.8×-1.3×

Profitability

See full
Gross margin65%+0.8pp
Operating margin21.4%+6.2pp
Net margin14.4%+2.2pp
FCF margin18.2%+1.3pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.2×+0.4×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Stryker’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 11:10 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000310764-26-000031
Net Sales by BusinessThree Months / 2026Three Months / 2025
Vascular517406
$3,207$3,056
Orthopaedics:
Knees$670$639
Hips460443
Trauma and Extremities1,035945
Ortho Tech646617
Spinal Implants2166

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Stryker's knees — net sales?
Stryker (SYK) reported knees — net sales of $670M in Q1 2026.
How has Stryker's knees — net sales changed year-over-year?
Stryker's knees — net sales increased by 4.9% year-over-year, from $639M to $670M.
What is the long-term trend for Stryker's knees — net sales?
Over 4 years (2021 to 2025), Stryker's knees — net sales has grown at a 9.5% compound annual growth rate (CAGR), from $1.85B to $2.66B.
What does knees — net sales mean?
This metric represents the total revenue generated from the sale of knee replacement implants, instrumentation, and related surgical products. It reflects the company's market performance within the reconstructive orthopedic segment, specifically targeting patients requiring total or partial knee arthroplasty. This revenue stream is a critical indicator of the company's competitive position in the elective surgery market and its ability to capture share in the global orthopedics industry.

Ask your AI about Stryker's knees — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude